Tundra Targeted Therapeutics is a clinical-stage biopharmaceutical company developing novel bispecific antibodies to treat cancer, with a focus on patients who have not responded to or are too vulnerable for current harsh therapies. The company was founded by cancer researchers and clinicians.

Merand Pharmaceuticals is a drug discovery company headquartered in Charlottesville, VA that is developing a novel microRNA therapeutic to treat Peripheral Arterial Disease. The company is associated with the University of Virginia Licensing & Ventures Group.

Advocacy organization for Americans 50+ on Social Security, Medicare, and healthcare policy, founded 1958. Not useful for Oluwadi/Osparna venture-intelligence surfacing in most cases -- primarily relevant to DoAyni's civic-influence layer.

Acclaim Technical Services (ATS) — language and intelligence-analysis services and mission IT for the U.S. intelligence community. Founded 2000; employee-owned (ESOP since 2013). Backed by Blue Delta Capital; acquisitive (Axis of Engineering, Global Consulting Services, Entegra Systems, OASIC Engineering, Alder Technology).

Materials science background from IQT. Does AI work. Small firm.

Human-centered digital services for federal and state government (product, engineering, design, cloud, modernization). Founded by core members of the HealthCare.gov rescue team; work includes Medicare Plan Finder and VA. ~500 employees. Backed by Blue Delta Capital; privately held.

Bacteriophage therapy for drug-resistant infections (PhageBank). I-270 corridor.

Adial Pharmaceuticals is a Charlottesville, Virginia-based clinical-stage biopharmaceutical company focused on developing treatments for alcohol use disorder and other addictions. Its lead therapeutic candidate targets the serotonin-3 receptor to reduce alcohol consumption. The company is publicly traded on the Nasdaq under the ticker ADIL.

Cloud-based UEBA and managed security platform for mid-market. Washington DC. MACH37 alumni (Fall 2016 cohort). Founders: Robert Johnston + Timothy Evans. Acquired by N-able November 2024.

Advaray (formerly BrachyFoam, Inc.) was an early-stage medical device company based in Charlottesville, Virginia developing devices for cancer therapy applications. The company was a University of Virginia Licensing & Ventures Group startup that was acquired by cancer therapy leader CQ Medical in October 2023.

Flight instruction (private, instrument, commercial, multi-engine, tailwheel, CFI) and aircraft rental; based in the main terminal at Leesburg Executive Airport (KJYO), 1001 Sycolin Rd SE Suite 1B, Leesburg, VA.

AgroSpheres is a Charlottesville, Virginia-based agribiotech company that develops and manufactures biological crop protection solutions designed to replace chemical pesticides and microplastics on U.S. farms. The company's AgriCell platform provides targeted, non-toxic pest control and was recognized by Time Magazine among top greentech companies in 2025; a new biomanufacturing facility launched in April 2026.

Applied Information Sciences (AIS) — cloud transformation, AI, application modernization and secure data solutions for the U.S. federal government and Fortune 1000. Employee-owned; Microsoft partner. Backed by Blue Delta Capital.

Benefits administration. Clarke Wallace (fmr IQT VP) is VP Strategic Account Executive.

Center-right think tank founded 1938. Free enterprise, foreign-policy hawkishness, economics-heavy scholarship. Not useful for Oluwadi/Osparna venture-intelligence surfacing in most cases -- primarily relevant to DoAyni's civic-influence layer.

Industrial bakery equipment manufacturer. HQ 2115 W Laburnum Ave, Richmond VA. Markel Ventures portfolio company.

Amida Technology Solutions — enterprise data management, interoperability and security for cybersecurity, healthcare and public-sector clients; major Department of Veterans Affairs partner. Founded 2013 by Peter L. Levin with Dmitry Kachaev and Matt McCall.

AMP3D is a Charlottesville, Virginia-based healthcare analytics company that provides predictive analytics monitoring via its proprietary SaaS platform CoMET. The platform processes big data from clinical settings to predict potentially catastrophic events such as emergent intubation and hemorrhage, enabling earlier intervention. AMP3D was acquired by Nihon Kohden in 2021.